Krebsimpfung: Hoffnung aus dem eigenen Immunsystem

How far has personalized cancer medicine come today? In this video, Chloe from the USA tells her story: She travels regularly to Tübingen to participate in a clinical trial for a rare form of liver cancer – fibrolamellar hepatocellular carcinoma. Researchers in Tübingen are working on innovative cancer vaccines and personalized immunotherapies. To do this, they analyze the genetic characteristics and surface structures of the tumor. These targeted therapies offer another pillar in cancer treatment – ​​alongside chemotherapy, radiation, and surgery. This video provides insights into: personalized cancer medicine cancer vaccines and immunotherapy clinical trials and research in Tübingen rare cancers the perspective of a patient and physician More about the study: https://www.medizin.uni-tuebingen.de/... #CancerResearch #Immunotherapy #CancerVaccine #LiverCancer #ClinicalTrial #Tübingen #CancerResearch #PersonalizedMedicine #FibrolamellarCarcinoma @fibrolamellarcancerfoundat6855